- Home
- FAAS vs VTVT Comparison
FAAS vs VTVT Comparison
Compare FAAS & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAAS
- VTVT
- Stock Information
- Founded
- FAAS 2021
- VTVT 2015
- Country
- FAAS Indonesia
- VTVT United States
- Employees
- FAAS N/A
- VTVT N/A
- Industry
- FAAS
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- FAAS
- VTVT Health Care
- Exchange
- FAAS NYSE
- VTVT Nasdaq
- Market Cap
- FAAS 34.6M
- VTVT 38.8M
- IPO Year
- FAAS N/A
- VTVT 2015
- Fundamental
- Price
- FAAS $0.25
- VTVT $16.90
- Analyst Decision
- FAAS
- VTVT Strong Buy
- Analyst Count
- FAAS 0
- VTVT 1
- Target Price
- FAAS N/A
- VTVT $35.00
- AVG Volume (30 Days)
- FAAS 513.0K
- VTVT 46.4K
- Earning Date
- FAAS 01-01-0001
- VTVT 05-08-2025
- Dividend Yield
- FAAS N/A
- VTVT N/A
- EPS Growth
- FAAS N/A
- VTVT N/A
- EPS
- FAAS N/A
- VTVT N/A
- Revenue
- FAAS $57,730,593.00
- VTVT $1,017,000.00
- Revenue This Year
- FAAS N/A
- VTVT N/A
- Revenue Next Year
- FAAS N/A
- VTVT N/A
- P/E Ratio
- FAAS N/A
- VTVT N/A
- Revenue Growth
- FAAS 38.16
- VTVT N/A
- 52 Week Low
- FAAS $0.23
- VTVT $12.12
- 52 Week High
- FAAS $10.63
- VTVT $29.19
- Technical
- Relative Strength Index (RSI)
- FAAS 31.53
- VTVT 48.17
- Support Level
- FAAS $0.27
- VTVT $16.40
- Resistance Level
- FAAS $0.36
- VTVT $17.50
- Average True Range (ATR)
- FAAS 0.06
- VTVT 2.00
- MACD
- FAAS -0.01
- VTVT -0.06
- Stochastic Oscillator
- FAAS 5.97
- VTVT 13.24
About FAAS DIGIASIA CORP
DigiAsia Corp operates as a holding company. The majority of DigiAsia's operations are currently conducted through its majority-owned entities, controlled entities and corporate joint venture. It is among the first embedded fintech as a service (EFaaS) companies in Indonesia serving business-to-business-to-consumer (B2B2C) customers, such as large corporations and state-owned enterprises, as well as business-to-business (B2B) customers, such as micro, small and medium-sized enterprise (MSME) merchants, across various segments. It aims to be a fintech-enabling platform in Southeast Asia by accelerating financial inclusion through its licenses and technology stack and combining the benefits of technological innovation with traditional financial services.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.